Delivered-To: john.podesta@gmail.com
Received: by 10.25.88.12 with SMTP id m12csp1767402lfb;
        Mon, 8 Feb 2016 18:12:38 -0800 (PST)
X-Received: by 10.182.86.98 with SMTP id o2mr12596715obz.27.1454983958689;
        Mon, 08 Feb 2016 18:12:38 -0800 (PST)
Return-Path: <>
Received: from na01-by2-obe.outbound.protection.outlook.com (mail-by2on0089.outbound.protection.outlook.com. [207.46.100.89])
        by mx.google.com with ESMTPS id 13si1164804oie.64.2016.02.08.18.12.38
        for <john.podesta@gmail.com>
        (version=TLS1_2 cipher=ECDHE-RSA-AES128-SHA bits=128/128);
        Mon, 08 Feb 2016 18:12:38 -0800 (PST)
Received-SPF: pass (google.com: domain of postmaster@na01-by2-obe.outbound.protection.outlook.com designates 207.46.100.89 as permitted sender) client-ip=207.46.100.89;
Authentication-Results: mx.google.com;
       spf=pass (google.com: domain of postmaster@na01-by2-obe.outbound.protection.outlook.com designates 207.46.100.89 as permitted sender) smtp.mailfrom=
Received: from BY2PR07CA057.namprd07.prod.outlook.com (10.141.251.32) by
 CO2PR07MB540.namprd07.prod.outlook.com (10.141.199.21) with Microsoft SMTP
 Server (TLS) id 15.1.396.15; Tue, 9 Feb 2016 02:12:37 +0000
Received: from BY2FFO11FD002.protection.gbl (2a01:111:f400:7c0c::101) by
 BY2PR07CA057.outlook.office365.com (2a01:111:e400:2c61::32) with Microsoft
 SMTP Server (TLS) id 15.1.403.16 via Frontend Transport; Tue, 9 Feb 2016
 02:12:36 +0000
Authentication-Results: spf=none (sender IP is 141.161.191.74)
 smtp.helo=mail.law.georgetown.edu; gmail.com; dkim=none (message not signed)
 header.d=none;gmail.com; dmarc=none action=none
 header.from=law.georgetown.edu;
Received-SPF: None (protection.outlook.com: mail.law.georgetown.edu does not
 designate permitted sender hosts)
Received: from mail.law.georgetown.edu (141.161.191.74) by
 BY2FFO11FD002.mail.protection.outlook.com (10.1.14.124) with Microsoft SMTP
 Server (TLS) id 15.1.409.7 via Frontend Transport; Tue, 9 Feb 2016 02:12:35
 +0000
Received: from LAW-MBX02.law.georgetown.edu ([169.254.2.236]) by
 LAW-CAS1.law.georgetown.edu ([141.161.191.74]) with mapi id 14.03.0248.002;
 Mon, 8 Feb 2016 21:12:28 -0500
From: "Joshua C. Teitelbaum" <jct48@law.georgetown.edu>
To: Julie Cohen <jec@law.georgetown.edu>
CC: Law Faculty and Visitors <LawFacultyandVisitors@law.georgetown.edu>, 
 =?windows-1252?Q?Meg=0D=0A_Jones?= <ma1318@georgetown.edu>
Subject: Re: Tech Law & Policy Colloquium: Monday, Feb. 8
Thread-Topic: Tech Law & Policy Colloquium: Monday, Feb. 8
Thread-Index: AQHRXGkQr7qLO9gnYkqSoVGl03he958iNJ2QgADRN9o=
Date: Tue, 9 Feb 2016 02:12:28 +0000
Message-ID: <394D99CC-8E0F-443A-AE14-84D162E1FBD5@law.georgetown.edu>
References: <D2D3DCC3.8D3D%jec@law.georgetown.edu>,<A7FD21C02D515640AB05AF6991FBD73463D89E7A@LAW-MBX01.law.georgetown.edu>
In-Reply-To: <A7FD21C02D515640AB05AF6991FBD73463D89E7A@LAW-MBX01.law.georgetown.edu>
Accept-Language: en-US
Content-Language: en-US
X-MS-Has-Attach:
X-MS-TNEF-Correlator:
Content-Type: multipart/alternative;
	boundary="_000_394D99CC8E0F443AAE1484D162E1FBD5lawgeorgetownedu_"
MIME-Version: 1.0
X-Auto-Response-Suppress: DR, RN, NRN, OOF, AutoReply
Return-Path: <>
X-EOPAttributedMessage: 0
X-Microsoft-Exchange-Diagnostics: 1;BY2FFO11FD002;1:TGZcrsYrlNpyuKFcRVYYYLd8Drj1uGrAqKP0CehqE7i0M06oi5GBxg3eeeAMo4wWo+m+JbqpAPaSuHNRAeY/zCrhSWtqYJg+rlhw4kbfZ1Kn3nN52/46SbtxKyQgctp3cuuLBFjoNNm4KlXAvQjvO+dK801anNgsj+RdOh3y5fuOhpB3LjEJVmTtaS6nnOggE610hVquwsdhuOnLRDw/egEGIOabgXeO8W6mI26//ufLPIHcwj2PuX8MYh4EBdI/BfeMVvwnyN1RB/xyGoYClMO+yDnw8ezxeSqURAXSgnvpLZ0qEUs6XmcSA0FfIveYm0LLXNW2hUYfe+Tw775/d3Kzj4SNXI/OrKTREXiSai3hEafwzUJPqJv1kSbxUH8D
X-Forefront-Antispam-Report:
	CIP:141.161.191.74;CTRY:US;IPV:NLI;EFV:NLI;SFV:NSPM;SFS:(10009020)(2970300002)(428002)(24454002)(199003)(53434003)(52044002)(189002)(377454003)(50986999)(78352003)(3900700001)(586003)(54356999)(76176999)(16601075003)(1220700001)(2950100001)(189998001)(960300001)(19617315012)(1096002)(2900100001)(300700001)(5001960100002)(790700001)(18717965001)(2906002)(104016004)(512944002)(101416001)(5008740100001)(15975445007)(33656002)(6806005)(5890100001)(89122001)(82746002)(87936001)(450100001)(106466001)(19625215002)(106116001)(84326002)(2171001)(88552002)(110136002)(107886002)(4001450100002)(5003600100002)(83716003)(105586002)(19580405001)(4001430100002)(19625305001)(16236675004)(102836003)(92566002)(42382002)(19580395003)(74826001)(4326007)(11634002)(53652003)(104396002)(42262002);DIR:OUT;SFP:1101;SCL:1;SRVR:CO2PR07MB540;H:mail.law.georgetown.edu;FPR:;SPF:None;MLV:sfv;A:0;MX:0;LANG:en;
X-Microsoft-Exchange-Diagnostics:
	1;CO2PR07MB540;2:vL1JLJJOpFGvYHuNPwllufY/g/ygotpeU1bfiMDLrRY6fCl4oyyILVoq26dc4YSwn2LLGD5AbqsG/7+LtY0NodY/tJ22GYdDZQ6ZnJ1jA/O0YIS2W+DgNCaaF+iYTbmk/YDgmwEqIq9bC0o9dscJ/A==;3:pO3oD6y/VBavUJqbbRb6qhGSqsKfOld2pfQ/ioQOGJEsFOkMWktpbdY0/Vs48n5bcf9c4eVl4XFc5pswo0h5eHBnqlSQ4EBQQxj5o/zClgJ4F9mu6glgKaO3Anmuqb4788yetZdhnGqveuvosEMwwNjQtKNNYzVfuLvovlBm70ipzpdSwkPW8Gkc5ijBOBmJEuTQTZ/lquCQIU6nq6l4uVmPeyMEt35FolnKAxgRAao=;25:wTVLxannSe6YiGE2mZC4Ldx3Wl26DhNZZy+vTYAPhZPSMDa82h6wLWjpARIKnVyfc+zEwFSwPDr/Cv3HRLVkCvQTpDa9qVbTLcM4XVKVfmxAcDgCD0a9Ze0nCHN8I1HN0SkXGPTF/867v1fI+YJRYdvYsNUbc5ZLsEYYzLJinRYUV/KsA4aD5CZujlODrP6Bx4MJB65CfpTSv1nlUsO/BAP1NvVRSECreYKSCT9Dtkill/9ehbCfzyiY8pfE3MBSFjtYUauSk6Z9XGpN7s40MYRrnP8q+CsyAPa8exJQLLLi+S8yRDudybBXOH+naEq0
X-Microsoft-Antispam: UriScan:;BCL:0;PCL:0;RULEID:;SRVR:CO2PR07MB540;
X-MS-Office365-Filtering-Correlation-Id: 36422bba-b647-4855-3e68-08d330f67a7a
X-LD-Processed: 935c2642-8489-46fc-97cc-1143c4b55ea3,ExtAddr
X-Microsoft-Exchange-Diagnostics:
	1;CO2PR07MB540;20:RARjjbnMpFfAioR39sll8XZP2N+iqB/nbNPVSn1cuI7PqnIGddIVBexag5Qbg8Lt4chMUuHEMxCo//bq5rhCwFc43tM+bGJzdqjX9LetznCbbmSSmAM17l33BnCWDSp+D/eNKzAgYAFar4lvSzNDiIwt98iqoLBhyhi2mssCGl28jN7UpgjnYmZeRQh6i81M8iPab5bgn0JdCkEOMYXt0UDtO/+sdxJ96rCl/YsjWzgVjcH+x4eq1WKv/ao21gopxpwwb+TjyS+anUzyqQ3J4dqyJCPBZHOFOP8OxcI+P5DtQW1Y9vav7NDWMIIGYXA2j+M1Ai+efuC2Bti6gEKAnY3hSKWqBfvtr03QiA1eiGj4sNN+BNVSsrt/uTie3UaD8xLC5hEWwxfWOXKygosaYr9H8xJzKuJRURIkSSJ9Jwg=;4:PTcgtB93ekSoJrQTR7B1D5r+iRLb5lmyo0GV+3Y8Re82edi91HrxsSMIJh/L1EhQRyy5g3Y/s/WgzN1VH6uUwK1Dsk6+xmmzTFy5yLolt9gO6tZeDyAft4uktrF6yQtwVJm3n0goxoTOtUm56zmKeABf4bLAVOzNSMzMQpMlrLSZwuUXcdmyaGBfFzTGOjmMLuroHK6w5bIENMKIX5a+8i+gSz0E4gFnxINUz+C1Jyf2mPMJds564VLA3xcppUCHVCYtrJu8aEemuYv5lPj9/JlbFCcGXiJZY/92AswK5yEq/T6VauQkXbyx6FtYBeXeWMz72bjFBPIEg70cgCv52ehWHbfmOzCgFgdhB14ZOUZNaju/1+ZyBFyyBJ+7z6/pVgbsWl63xSSiNIdR6eej9ImIFXj5OpBw8aIh54ojKOOE8eis8r3vpmmyc6iRrMqOV0urm5Lh7D3sipEPFNrXsw==
X-Microsoft-Antispam-PRVS:
	<CO2PR07MB540E16284091763CE02843EB8D60@CO2PR07MB540.namprd07.prod.outlook.com>
X-Exchange-Antispam-Report-Test: UriScan:(76009858676777);
X-Exchange-Antispam-Report-CFA-Test:
	BCL:0;PCL:0;RULEID:(601004)(2401047)(5005006)(13018025)(13016025)(8121501046)(10201501046)(3002001);SRVR:CO2PR07MB540;BCL:0;PCL:0;RULEID:;SRVR:CO2PR07MB540;
X-Forefront-PRVS: 08476BC6EF
X-Microsoft-Exchange-Diagnostics:
	=?us-ascii?Q?1;CO2PR07MB540;23:NHy7pB7GDygN6bSICyiOLuaQSMIsIR5nwXmb4LDaSy?=
 =?us-ascii?Q?Nfwjc035tGt8KjyAZibFAiQdeS6bFw45SowXLiO2Ly+HB7vk8aS72tA9g0v4?=
 =?us-ascii?Q?lah86Te3xsnF+3xc9/I8B6vjZ5SFSMmCYyt1Ka8Tf9eVxACU9XonFbSbDV0g?=
 =?us-ascii?Q?xIaoZ2+vLuKv4nsz5QsChLUJXJeRTu8c+aFPtABRd2dSGipNPXR2FBL3OBiX?=
 =?us-ascii?Q?Wt8qlK0RDbfiY5+ZpDdnT06EWXkYgw1cqifdQj6s0GujdMZVWGxjCllWFp/v?=
 =?us-ascii?Q?3chdhYlPnLQfxvewxgjEiaQDph30RM8/6F1fIDuRpODFZcpzwiW/cmtyWYju?=
 =?us-ascii?Q?FR/C0+ZJn85x0cVZU/WCUikPB/DnPFqcum+gG7gWUD/KshhDLHgQwRV1LGdW?=
 =?us-ascii?Q?DaPCj6rVxT1x6dXgdqLsSQwzIjJGuE6ipIcgz5CerJfl5Xg4hv7FuqKGrbuR?=
 =?us-ascii?Q?AVuXv90yJpO2w+pny5YZYjqDopY7jowB9aFMTH6sPPCN9hh1nBCY5NzXlZ+M?=
 =?us-ascii?Q?7IxrozL4o1stdmspB6iNTbkdkcJx6qC2gTCy7NrCGCOppsnOydgMBQvs2nlU?=
 =?us-ascii?Q?X36nqGoGXjP82zzncllQBrhVx1RX245CLyFxYHdxMTBjDs4/Gs1hzJxfsmv7?=
 =?us-ascii?Q?NnSJ1/QR1GfFIh97HmLy8590DuulkzDhZQkdhN2dv+B7wLc/vrw7HcbQzNJX?=
 =?us-ascii?Q?BMvYBTFe9eI9mBRvJkmu+IBjNzyhN9ojgKNV6Vf/txKns/hWwMURw4iRd6g8?=
 =?us-ascii?Q?WokO3sEsDh2qkLIvgB1hjpUQ2pw+vOK8Qzs7/8xf5p1MpYRLgsvqP1KVMJHz?=
 =?us-ascii?Q?aMhcEdRJjSQ8VtybczuBumAtuI5oA/bVZzbPrOPFbFxoz66C9QrdheFEB/JK?=
 =?us-ascii?Q?wysoFVluOsxxMEwlRJ/aXTcDTfumvqwg6naac6rGLKvKizOUs85Cad1z276l?=
 =?us-ascii?Q?stnThEAFh37BiPjxE1qIiaL8+V6BgaP1kjJ3ULY6FzjWIGGGJe5Z5FIFhOrJ?=
 =?us-ascii?Q?PndtfsDJJpa7/TeZUPTq8pbezZ0mqeSvN3wkx2IGXYp4acJ81RPPgEHv6nvf?=
 =?us-ascii?Q?fpyVBIgR5ihe1DCyFTnNIMZbUWt4kmUQl+XQ2b3eJKV36y4O74XVbXoxDBF/?=
 =?us-ascii?Q?8RHpuxd7frP8G6PZsqCepBtKLS6Yi0fZeoLq7fFHDjUpfgYuk4f/ZjiMtQtB?=
 =?us-ascii?Q?owrwlrtaWwxbi6qQjeCgP0uLwSu532U5m4vZEhb6eNlQdqOQlbheEkefzWWo?=
 =?us-ascii?Q?qZj1FBdo6OG8EVRaLa9VYuBUuGE7c/U5l7X6dItbFzq2b1fDPAOBLdWzHRof?=
 =?us-ascii?Q?IPskMa0VYD8VmlTWCQC7xTel41bvzOYGhS3cZ0UHEW6eK4v7uStZibAqID8s?=
 =?us-ascii?Q?J2Ddf1+mQ1XFqC4gkp4KS40DW60QQbHJkXmiYsiS6/kYjbLDYtwsTkziF/i5?=
 =?us-ascii?Q?LGrrYnbGeOmgU/BRTTZizwTh+EEbpjYtvDEgrRaL0QbKC8Tm/bu1azgq1pwt?=
 =?us-ascii?Q?fYcB/IynVcnkzh5vOiiEEvSZyBnv+y5aO9liviHs3fFMaizV7D2O1W2cZYaC?=
 =?us-ascii?Q?M6MeS5xFSACWXKj43Y4jtv0Y3DOl6W4CHMIUTlwVhimnPs4VzRyxkTNdeRmK?=
 =?us-ascii?Q?WS+wyjDrFOzhdaB1aE9L4f+Iewp9FvwtN57La64QGbAgrp3L91KM0XrBRbw0?=
 =?us-ascii?Q?copmp/XTmb2A7TVDWRHsjMuQ=3D=3D?=
X-Microsoft-Exchange-Diagnostics:
	1;CO2PR07MB540;5:1Fri0Yo+j/EW8q5UcF4/pxWbEc+Vzk/dFcHEeeLdnnd6crCQcror+Kmy8n3e6C1bw0ywWTFiE5fdXrBzMkYq3EflcrqqFnryWTwLL+uGfJ67zxOMclkphIblsPAPUAPFrSIF7KSCVAKvc98eOJeMpA==;24:8tCnKHYz8LmCeTjt+DCrnHCT1p7AGaU7tauO6j3vXMcBu7EJjOHBgfYfpv7z3u7bHnYvzjO3HnqrSRkpBfB+z4QWyn8ZmC2KeH6dYHJM5CE=
SpamDiagnosticOutput: 1:23
SpamDiagnosticMetadata: NSPM
X-OriginatorOrg: law.georgetown.edu
X-MS-Exchange-CrossTenant-OriginalArrivalTime: 09 Feb 2016 02:12:35.9767
 (UTC)
X-MS-Exchange-CrossTenant-Id: 935c2642-8489-46fc-97cc-1143c4b55ea3
X-MS-Exchange-CrossTenant-OriginalAttributedTenantConnectingIp: TenantId=935c2642-8489-46fc-97cc-1143c4b55ea3;Ip=[141.161.191.74];Helo=[mail.law.georgetown.edu]
X-MS-Exchange-CrossTenant-FromEntityHeader: HybridOnPrem
X-MS-Exchange-Transport-CrossTenantHeadersStamped: CO2PR07MB540

--_000_394D99CC8E0F443AAE1484D162E1FBD5lawgeorgetownedu_
Content-Type: text/plain; charset="Windows-1252"
Content-Transfer-Encoding: quoted-printable

Julie - I'm very sorry I missed today's colloquium. Hopefully Neel was able=
 to make it; this should have been right up his alley.

Josh

On Feb 8, 2016, at 8:45 AM, Julie Cohen <jec@law.georgetown.edu<mailto:jec@=
law.georgetown.edu>> wrote:

Dear Colleagues,

Just a reminder about today=92s Tech Law and Policy Colloquium speaker.  Ev=
en if you are not a patent maven, you might enjoy it.  It=92s an empirical =
paper that uses bibliometric techniques to study patent citation networks. =
We=92re in McD 344 at 1:20; please feel free to join in.

Best, Julie

From: Julie Cohen
Sent: Sunday, January 31, 2016 3:51 PM
To: Law Faculty and Visitors
Cc: Meg Jones
Subject: Re: Tech Law & Policy Colloquium: Monday, Feb. 8

Dear Colleagues,

Next Monday, Feb. 8, the Technology Law and Policy Colloquium speaker will =
be Andrew Torrance of the University of Kansas and MIT. Andrew=92s paper, =
=93Are Litigated Patents More Important?,=94 is attached. We will meet from=
 1:20-3:20 in McDonough 344, and you are welcome to join us.

Here is the abstract:


Various correlates of patent value, influence, and importance have been pro=
posed. These include payment of maintenance fees, size of patent family, nu=
mber of claims, and how frequently a patent has been litigated. We test two=
 hypotheses: (1) litigated patents tend to be more important than average; =
and (2) patent importance rises with the level of court (that is, district =
court, Court of Appeals for the Federal Circuit, and United States Supreme =
Court) patent litigation reaches. Citations are widely regarded as useful i=
ndicators of the technological importance of inventions disclosed by patent=
s, as well as of the economic value of that patent. Using a hierarchical me=
thod of analysis, we constructed a graph of the complete citation network o=
f all United States patents issued from 1976 to 2014, and assigned every no=
de (that is, an individual patent) an objective importance score. We set th=
e mean importance score for all patents to 1.0. Importance scores scale dir=
ectly with numerical value, so 10.0 indicates a patent ten times as importa=
nt as the mean and 0.1 indicates a patent only one tenth as important as th=
e mean. Using a dataset of patents litigated to a decision at a district co=
urt, the CAFC, and the Supreme Court from 2000-2014, and patent importance =
scores assigned to each litigated patent, we tested hypotheses (1) and (2).=
 Preliminary results indicate that patents litigated in district court have=
 a mean importance score of about 4.5, those litigated in the CAFC have a m=
ean importance score of about 6.5, and patents litigated in the Supreme Cou=
rt have a mean importance score of about 8.3. This suggests that (1) litiga=
ted patents do appear be considerably more important than average and (2) p=
atent importance rises markedly from district court to CAFC to Supreme Cour=
t. We will complete our study this summer.

All best, Julie

Julie E. Cohen
Mark Claster Mamolen Professor of Law & Technology
Georgetown University Law Center
jec@law.georgetown.edu<mailto:jec@law.georgetown.edu>
http://www.juliecohen.com<http://www.juliecohen.com/>


<Torrance & West - Are Litigated Patents Important - January 29, 2016.pdf>

--_000_394D99CC8E0F443AAE1484D162E1FBD5lawgeorgetownedu_
Content-Type: text/html; charset="Windows-1252"
Content-Transfer-Encoding: quoted-printable

<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DWindows-1=
252">
</head>
<body dir=3D"auto">
<div>Julie - I'm very sorry I missed today's colloquium. Hopefully Neel was=
 able to make it; this should have been right up his alley.<br>
<br>
Josh</div>
<div><br>
On Feb 8, 2016, at 8:45 AM, Julie Cohen &lt;<a href=3D"mailto:jec@law.georg=
etown.edu">jec@law.georgetown.edu</a>&gt; wrote:<br>
<br>
</div>
<blockquote type=3D"cite">
<div>
<meta name=3D"Generator" content=3D"Microsoft Word 12 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-priority:99;
	color:purple;
	text-decoration:underline;}
p
	{mso-style-priority:99;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
span.EmailStyle18
	{mso-style-type:personal-reply;
	font-family:"Calibri","sans-serif";
	color:#1F497D;}
.MsoChpDefault
	{mso-style-type:export-only;
	font-size:10.0pt;}
@page WordSection1
	{size:8.5in 11.0in;
	margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext=3D"edit" spidmax=3D"1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext=3D"edit">
<o:idmap v:ext=3D"edit" data=3D"1" />
</o:shapelayout></xml><![endif]-->
<div class=3D"WordSection1">
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:&quot;Ca=
libri&quot;,&quot;sans-serif&quot;;color:#1F497D">Dear Colleagues,<o:p></o:=
p></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:&quot;Ca=
libri&quot;,&quot;sans-serif&quot;;color:#1F497D"><o:p>&nbsp;</o:p></span><=
/p>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:&quot;Ca=
libri&quot;,&quot;sans-serif&quot;;color:#1F497D">Just a reminder about tod=
ay=92s Tech Law and Policy Colloquium speaker. &nbsp;Even if you are not a =
patent maven, you might enjoy it.&nbsp; It=92s an empirical paper that
 uses bibliometric techniques to study patent citation networks. We=92re in=
 McD 344 at 1:20; please feel free to join in.<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:&quot;Ca=
libri&quot;,&quot;sans-serif&quot;;color:#1F497D"><o:p>&nbsp;</o:p></span><=
/p>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:&quot;Ca=
libri&quot;,&quot;sans-serif&quot;;color:#1F497D">Best, Julie<o:p></o:p></s=
pan></p>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:&quot;Ca=
libri&quot;,&quot;sans-serif&quot;;color:#1F497D"><o:p>&nbsp;</o:p></span><=
/p>
<div>
<div style=3D"border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0in =
0in 0in">
<p class=3D"MsoNormal"><b><span style=3D"font-size:10.0pt;font-family:&quot=
;Tahoma&quot;,&quot;sans-serif&quot;">From:</span></b><span style=3D"font-s=
ize:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;"> Julie Co=
hen
<br>
<b>Sent:</b> Sunday, January 31, 2016 3:51 PM<br>
<b>To:</b> Law Faculty and Visitors<br>
<b>Cc:</b> Meg Jones<br>
<b>Subject:</b> Re: Tech Law &amp; Policy Colloquium: Monday, Feb. 8<o:p></=
o:p></span></p>
</div>
</div>
<p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p>
<div>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:&quot;Ca=
libri&quot;,&quot;sans-serif&quot;;color:black">Dear Colleagues,</span><spa=
n style=3D"font-size:10.5pt;font-family:&quot;Calibri&quot;,&quot;sans-seri=
f&quot;;color:black"><o:p></o:p></span></p>
</div>
<div>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;color:black">&nbsp;<=
o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;color:black">Next Mo=
nday, Feb. 8, the Technology Law and Policy Colloquium speaker will be Andr=
ew Torrance of the University of Kansas and MIT. Andrew=92s paper, =93Are L=
itigated Patents More Important?,=94 is attached.
 We will meet from 1:20-3:20 in McDonough 344, and you are welcome to join =
us.<o:p></o:p></span></p>
</div>
<div>
<p class=3D"MsoNormal"><span style=3D"color:black"><o:p>&nbsp;</o:p></span>=
</p>
</div>
<div>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;color:black">Here is=
 the abstract:<o:p></o:p></span></p>
</div>
<div>
<p class=3D"MsoNormal"><span style=3D"font-size:10.5pt;font-family:&quot;Ca=
libri&quot;,&quot;sans-serif&quot;;color:black"><o:p>&nbsp;</o:p></span></p=
>
</div>
<div>
<p style=3D"margin:0in;margin-bottom:.0001pt;min-height: 15px"><span style=
=3D"color:black">Various correlates of patent value, influence, and importa=
nce have been proposed. These include payment of maintenance fees, size of =
patent family, number of claims, and
 how frequently a patent has been litigated. We test two hypotheses: (1) li=
tigated patents tend to be more important than average; and (2) patent impo=
rtance rises with the level of court (that is, district court, Court of App=
eals for the Federal Circuit, and
 United States Supreme Court) patent litigation reaches. Citations are wide=
ly regarded as useful indicators of the technological importance of inventi=
ons disclosed by patents, as well as of the economic value of that patent. =
Using a hierarchical method of analysis,
 we constructed a graph of the complete citation network of all United Stat=
es patents issued from 1976 to 2014, and assigned every node (that is, an i=
ndividual patent) an objective importance score. We set the mean importance=
 score for all patents to 1.0. Importance
 scores scale directly with numerical value, so 10.0 indicates a patent ten=
 times as important as the mean and 0.1 indicates a patent only one tenth a=
s important as the mean. Using a dataset of patents litigated to a decision=
 at a district court, the CAFC,
 and the Supreme Court from 2000-2014, and patent importance scores assigne=
d to each litigated patent, we tested hypotheses (1) and (2). Preliminary r=
esults indicate that patents litigated in district court have a mean import=
ance score of about 4.5, those litigated
 in the CAFC have a mean importance score of about 6.5, and patents litigat=
ed in the Supreme Court have a mean importance score of about 8.3. This sug=
gests that (1) litigated patents do appear be considerably more important t=
han average and (2) patent importance
 rises markedly from district court to CAFC to Supreme Court. We will compl=
ete our study this summer.&nbsp;<o:p></o:p></span></p>
</div>
<div>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:&quot;Ca=
libri&quot;,&quot;sans-serif&quot;;color:black">&nbsp;&nbsp;<o:p></o:p></sp=
an></p>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:&quot;Ca=
libri&quot;,&quot;sans-serif&quot;;color:black">All best, Julie<o:p></o:p><=
/span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:&quot;Ca=
libri&quot;,&quot;sans-serif&quot;;color:black">&nbsp;<o:p></o:p></span></p=
>
<p class=3D"MsoNormal"><span style=3D"color:black">Julie E. Cohen</span><sp=
an style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,&quot;sans-ser=
if&quot;;color:black"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"color:black">Mark Claster Mamolen Pro=
fessor of Law &amp; Technology</span><span style=3D"font-size:11.0pt;font-f=
amily:&quot;Calibri&quot;,&quot;sans-serif&quot;;color:black"><o:p></o:p></=
span></p>
<p class=3D"MsoNormal"><span style=3D"color:black">Georgetown University La=
w Center</span><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&qu=
ot;,&quot;sans-serif&quot;;color:black"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"color:black"><a href=3D"mailto:jec@la=
w.georgetown.edu"><span style=3D"color:purple">jec@law.georgetown.edu</span=
></a></span><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;=
,&quot;sans-serif&quot;;color:black"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"color:black"><a href=3D"http://www.ju=
liecohen.com/"><span style=3D"color:purple">http://www.juliecohen.com</span=
></a></span><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;=
,&quot;sans-serif&quot;;color:black"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:&quot;Ca=
libri&quot;,&quot;sans-serif&quot;;color:black">&nbsp;<o:p></o:p></span></p=
>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:&quot;Ca=
libri&quot;,&quot;sans-serif&quot;;color:black"><o:p>&nbsp;</o:p></span></p=
>
</div>
</div>
</div>
</blockquote>
<blockquote type=3D"cite">
<div>&lt;Torrance &amp; West - Are Litigated Patents Important - January 29=
, 2016.pdf&gt;</div>
</blockquote>
</body>
</html>

--_000_394D99CC8E0F443AAE1484D162E1FBD5lawgeorgetownedu_--
